Structured psychotherapeutic support for patients with mood disorders reinforces the mood and quality of life benefits of GLP-1 RAs by helping patients adhere to their treatment plan and promoting behavioral activation and reduction in weight- or metabolism-related avoidance or demoralization. The gene discussed is GLP1R; the disease is mood disorder.